2024年：
1. Peiguang Zhang#, Jieqiong Cao#, Xujing Liang#, Zijian Su, Bihui Zhang, Zhenyu，Wang, Junye Xie, Gengrui Chen, Xue Chen, Jinting Zhang, Yanxian Feng, Qin Xu,, Jianping Song, An Hong***, Xiaojia Chen**, Yibo Zhang*. Lian-Mei-Yin formula alleviates diet-induced hepatic steatosis by suppressing the Yap1/FOXM1 pathway dependent lipid synthesis, Acta Biochimica et Biophysica Sinica，in press
2023年：
1. Yibo Zhang*, Liu He*, Yiqi Yang, Jieqiong Cao,Zijian Su, Bihui Zhang, Huiying Guo, ZhenyuWang, Peiguang Zhang, Junye Xie, Jieruo Li,Jinshao Ye, Zhengang Zha, Hengyi Yu, An Hong#, Xiaojia Chen#. Triclocarban Triggers Osteoarthritis Via DNMT1-mediated Epigenetic Modification and Suppressionof COL2A in Cartilage Tissues. Journal of Hazardous Materials2023，447:130747.
2. Jieqiong Ca#, Yibo Zhang#, Yiqi Yang†, Junye Xie, Zijian Su, Fu Li, Jingsheng Li, Bihui Zhang, Zhenyu Wang, Peiguang Zhang, Zhixin Li, Liu He, Hongwei Liu, Wenjie Zheng, Shuixing Zhang*, An Hong* and Xiaojia Chen* Turning gray selenium and sublimed sulfur into a nanocomposite to accelerate tissue regeneration by isothermal recrystallization. Journal of Nanobiotechnology, (2023) 21（1）:57
3. Zijian Su#, Yibo Zhang#, Jieqiong Cao#, Yuanmeng Sun, Yuling Cai, Bihui Zhang, Liu He, Zilei Zhang,Junye Xie, Qilin Meng, Lin Luo, Fu Li, Jingsheng Li, Jinting Zhang, Xiaojia Chen* and An Hong*. Hyaluronic acid‑FGF2‑derived peptide bioconjugates for suppression of FGFR2 and AR simultaneously as an acne antagonist.Journal of Nanobiotechnology, (2023) 21（1）:55
4. Qilin Meng#, Lin Luo#, Minghua Lei, Zhiqi Chen, Yuanmeng Sun, Xue Chen, Zhaodong Zhai, Yibo Zhang, Jieqiong Cao, Zijian Su, Fu Li, Jingsheng Li,An Hong*, and XiaojiaChen*. Inhibition of FGFR2 Signaling by Cynaroside Attenuates Liver Fibrosis. Pharmaceuticals , 2023, 16, 548.
5. Yiqi Yang†, Yibo Zhang†, Jieqiong Cao†, Zijian Su, Fu Li, Peiguang Zhang, Bihui Zhang, Rongzhan Liu, Linhao Zhang, Junye Xie, Jingsheng Li, Jinting Zhang, Xiaojia Chen* and An Hong*. FGFR4 and EZH2 inhibitors synergistically induce hepatocellular carcinoma apoptosis via repressing YAP signaling. Journal of Experimental & Clinical Cancer Research, 2023, 42:96
6. Fu Li#, Minghua Lei#, Junye Xie，Shujun Guo, Weicai Li, Xiujuan Ren, Teng Wang, Songxiong Lin , Qiuling Xie#, and Xiaojia Chen#. Discovery and Characteristics of a Novel Antitumor Cyclopeptide Derived from Shark.Bioengineering. 2023, 10(6), 674.
7. Yiqi Yang#, Bihui Zhan#, Junye Xie, Jingsheng Li, Jia Liu, Rongzhan Liu,Linhao Zhang, Jinting Zhang, Zijian Su, Fu Li, Leisheng Zhang*, An Hong*, and Xiaojia Chen*. CH02 peptide promotes ex vivo expansion of umbilical cord blood-derived CD34+ hematopoietic stem/progenitor cells. Acta Biochim Biophys Sin 2023, 55(8):1-10
8. Junye Xie#, Fu Li#, Yuling Cai, Jinting Zhang, Yibo Zhang, Zhaodong Zhai, Zijian Su, Xue Chen, Minghua Lei, Rongzhan Liu, Weicai Li, Dianlong Kang, Xiaojia Chen *, An Hong*.SAIF suppresses the angiogenesis via blocking VEGF-VEGFR2-ERK signaling and facilitates tumor treatment. Heliyon，9（2023）：e18240
2022年：A1（1）区1篇
l Jieqiong Cao#, Yibo Zhang#, Peiguang Zhang, Zilei Zhang, Bihui Zhang, Yanxian Feng,Zhixin Li , Yiqi Yang, Qilin Meng, Liu He, Yulin Cai, Zhenyu Wang, Jie Li, Xue Chen,Hongwei Liu, An Hong *, Wenjie Zheng*, Xiaojia Chen*. Turning gray selenium into a nanoaccelerator of tissue regeneration by PEG modification，Bioactive Materials，2022，15：131-144
2021年：（通讯3）
1. Ying Zhao#, Qiang Wang#, Chen Xie, Yuling Cai, Xue Chen, Yuhui Hou, Liu He, Jianping Li, Min Yao, Shuangxi Chen, Wutian Wu, Xiaojia Chen*,An Hong* . Peptide ligands targeting FGF receptors promote recovery from dorsal root crush injury via AKT/mTOR signaling. Theranostics 2021; 11(20): 10125-10147.; doi:10.7150/thno.62525;
2. Yuan Jin*, Qilin Meng*, Bihui Zhang, Chen Xie, Xue Chen, Baoqing Tian, Jiakang，Wang, Tsung-Chieh Shih, Yibo Zhang, Jieqiong Cao, Yiqi Yang, Size Chen, Xinyuan，Guan, Xiaojia Chen#, An Hong#. Cancer-associated fibroblast-derived exosomal miR-3656 promotes the development and progression of esophageal squamous cell carcinoma via the ACAP2/PI3K-AKT signaling pathway. Int. J. Biol. Sci. 2021; 17(14): 3689-3701. doi: 10.7150/ijbs.62571
3. Wang, Y.*; Li, Y. *; Cao, J.*;Meng, Q.; Li, X.; Zhang, Y.; Lam, K.S.; Hong, A.; Liu, R.#; Chen, X#. Development and Characterization of a Novel Peptide Drug Conjugate with DM1 for Treatment of FGFR2-Positive Tumors. Biomedicines 2021, 9(8): 849. doi.org/ 10.3390/biomedicines9080849
4. Jianxin Yan*, Jiaji Liang*, Yingxuan Cao, Mariya M. El Akkawi, Xuan Liao, Xiaojia Chen, Chengzhi Li, Kecheng Li, Guanghui Xie and Hongwei Liu#. Efficacy of topical and systemic transplantation of mesenchymal stem cells in a rat model of diabetic ischemic wounds. Stem Cell Research & Therapy (2021) 12:220 doi.org/10.1186/s13287-021-02288-8
2020年（2篇，通讯2）
1. Yibo Zhang*,Man Ouyang*, HailongWang, Bihui Zhang, Wenhua Guang,Ruiwu Liu2 Xiaocen Li2 Tsung-Chieh Shih, Zhixin Li, Jieqiong Cao, Qiling Meng, Zijian Su, Jinshao Ye, Feng Liu, An Hong#, Xiaojia Chen#. A cyclic peptide retards the proliferation of DU145 prostate cancer cells in vitro and in vivo through inhibition of FGFR2，MedComm. 2020;1:362–375.DOI: 10.1002/mco2.48
2. Qiang Wang , Ying Zhao , Xiaojia Chen# & An Hong#.Virtual screening of approved clinic drugs with main protease (3CLpro) reveals potential inhibitory effects on SARS-CoV-2. Journal of Biomolecular Structure and Dynamics. 2022,40(1/2)： 685-695； Published online: 10 Sep 2020, https://doi.org/10.1080/07391102.2020.1817786